quadraScope

quadraScope is a Boston-based venture capital firm investing in early-stage longevity and healthy-aging companies. It targets startups developing pharmaceuticals, diagnostics, software, equipment, and devices aimed at biological age reversal, disease treatment, and prevention. The firm's sector focus centers on biogerontology, using the "Hallmarks of Aging" scientific framework to guide investment selection across genomic instability, cellular senescence, and related aging mechanisms. It leans heavily on a scientific advisory board of geroscientists, including Aubrey de Grey and Nir Barzilai, for deal vetting. Notable portfolio companies include Repair Biotechnologies, Nanotics, MatterBio, Cosmica, Immunis, and Healthy Longevity Clinic. quadraScope's investment approach emphasizes scientific rigor and cross-disciplinary vetting, targeting Seed and early-stage ventures with technologies addressing specific biological hallmarks of aging. The firm's investment criteria prioritize scientifically credible, mechanism-based approaches to aging and disease over broad wellness plays. It draws on its Boston and Tel Aviv locations to access concentrated biotech academia, industry talent, and research pipelines in the longevity space.